Dyadic International Inc (DYAI)
Healthcare
Biotechnology
1.10 $
-1.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Dyadic International Inc (DYAI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 75.1% of the shares are freely tradable; institutional investors hold 15.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
15.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
25.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
75.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
0.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
36Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Apis Capital Advisors, LLC | 3.49 | 1,270,972 | -14.7 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.55 | 928,233 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 2.51 | 914,960 | +0.0 | 12/31/2025 |
| Chapin Davis Inc | 2.44 | 888,004 | +0.0 | 03/31/2026 |
| BB&T Corp. | 0.90 | 326,200 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.86 | 313,508 | +3.9 | 03/31/2026 |
| BlackRock Inc | 0.76 | 275,425 | +2.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.60 | 583,627 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.95 | 344,606 | +0.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.41 | 151,125 | -0.4 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.